This is in consistence with a previous report stated that Notch1 inhibitors; such as CNC in the present case, may potentiate the effect of DNA damaging agents like Doxo in a variety of breast cancer cell lines34. This evidence concerns the gene NOTCH1 and breast carcinoma.